MBIO MUSTANG BIO, INC.: institutional ownership and insider trading
25 funds reported holding $435K of MUSTANG BIO, INC. in their latest 13F filings; in Q2 2026 funds net bought $21.7K, with 5 new positions and 3 funds selling out; over the last 12 months insiders bought $237 and sold $241 on the open market.
MBIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.07M, EPS -0.16
- Quarter ended Mar 31, 2026: revenue n/a, net income −$955K, EPS -0.14
- Quarter ended Dec 31, 2025: revenue n/a, net income −$538K, EPS -0.08
- Quarter ended Sep 30, 2025: revenue n/a, net income −$468K, EPS -0.07
Famous investors holding MBIO
- Ken Griffin (Citadel Advisors): $41.7K, 0.0% of the portfolio
Largest institutional holders of MBIO
- Kestra Advisory Services, LLC — $138K
- BlackRock, Inc. (BLK) — $59.5K
- VANGUARD GROUP INC — $56.8K
- CITADEL ADVISORS LLC — $41.7K
- GEODE CAPITAL MANAGEMENT, LLC — $29.7K
- CFO4Life Group, LLC — $23.5K
- VANGUARD FIDUCIARY TRUST CO — $22.5K
- VANGUARD CAPITAL MANAGEMENT LLC — $18.0K
- XTX Topco Ltd — $10.3K
- Virtu Financial LLC — $10.0K
Recent MBIO insider trades
- Dec 30, 2025: Herskowitz Neil sold 247 shares ($237)
- Dec 30, 2025: Chill Adam J. sold 4 shares ($4)
- Dec 30, 2025: Jin David bought 247 shares ($237)
5%+ owners
- Fortress Biotech, Inc.: 8.0% (Schedule 13D/A, filed Jan 5, 2026)
Who owns the most MBIO stock?
The largest institutional holders of MUSTANG BIO, INC. in the latest 13F filings are Kestra Advisory Services, LLC ($138K), BlackRock, Inc. (BLK) ($59.5K), VANGUARD GROUP INC ($56.8K).
Are insiders buying or selling MBIO?
Over the last 12 months insiders bought $237 and sold $241 of MUSTANG BIO, INC. stock on the open market (SEC Form 4).
Which famous investors own MBIO?
Ken Griffin.